The use of the levonorgestrel-releasing intrauterine system in the management of menorrhagia in women with hemostatic disorders.

Abstract

OBJECTIVE:

The study was undertaken to evaluate the levonorgestrel-releasing intrauterine system (LNG-IUS) in managing menorrhagia associated with hemostatic disorders.

STUDY DESIGN:

Retrospective notes review.

RESULTS:

Nineteen of 28 (68%) patients experienced improvement with the LNG-IUS. There was nonacceptance by 9 of 28 (32%) who refused the LNG-IUS or had it definitively removed.

CONCLUSION:

The LNG-IUS should be considered when managing menorrhagia because surgery carries additional risks in this subset of patients.

• Authors: Zoe E Schaedel, Gerry Dolan, Martin C Powell
• Journal: American journal of obstetrics and gynecology (Am J Obstet Gynecol) Vol. 193 Issue 4 Pg. 1361-3 (Oct 2005) ISSN: 1097-6868 [Electronic] United States
• PMID: 16202726 (Publication Type: Journal Article)

Chemical References

• Levonorgestrel

Topics

• Female
• Hemostatic Disorders (complications)
• Humans
• Levonorgestrel (administration & dosage)
• Menorrhagia (complications, drug therapy)
• Retrospective Studies